![Mittie Doyle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mittie Doyle
Technik-/Wissenschafts-/F&E-Leiter bei
AVALO THERAPEUTICS, INC.
Vermögen: 825 827 $ am 31.05.2026
Profil
Mittie Doyle is currently Director at Cullinan Therapeutics, Inc. since 2025, Director at Santa Ana Bio, Inc., and Chief Medical Officer at Avalo Therapeutics, Inc. since 2024.
Former positions include Senior Medical Director at Alexion Pharmaceuticals, Inc. from 2012 to 2015, Independent Director at DICE Therapeutics, Inc. from 2022 to 2023, Vice President-Clinical Research at Flexion Therapeutics, Inc. from 2015 to 2016, VP-Global Therapeutic, Head-Research & Development at CSL Behring LLC from 2017 to 2021, Vice President-Global Development Lead at Shire Pharmaceuticals, Inc. from 2016 to 2017, and Chief Medical Officer at Aro Biotherapeutics Co. from 2021 to 2024.
Education includes undergraduate studies at Princeton University and a doctorate from Yale School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 51.776 ( 0,1 % ) | 825 827 $ | 31.05.2026 |
Aktive Positionen von Mittie Doyle
| Unternehmen | Position | Beginn |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 15.07.2024 |
| CULLINAN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 07.08.2025 |
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mittie Doyle
| Unternehmen | Position | Ende |
|---|---|---|
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
| DICE THER | Direktor/Vorstandsmitglied | 09.08.2023 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01.10.2017 |
| FLEXION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2016 |
Ausbildung von Mittie Doyle
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
43
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology Develops oral immunology and other therapeutic products | Health Technology |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Health Technology |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
